- Home
- RY vs ABT Comparison
RY vs ABT Comparison
Compare RY & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RY | ABT |
|---|---|---|
| Founded | 1864 | 1888 |
| Country | Canada | United States |
| Employees | 100000 | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.4B | 189.6B |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | RY | ABT |
|---|---|---|
| Price | $163.62 | $112.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 17 |
| Target Price | ★ $162.00 | $140.24 |
| AVG Volume (30 Days) | 1.0M | ★ 7.1M |
| Earning Date | 01-01-0001 | 04-23-2026 |
| Dividend Yield | ★ 2.75% | 2.30% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.72 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $17.12 | $8.92 |
| Revenue Next Year | $4.56 | $7.39 |
| P/E Ratio | ★ $17.01 | $29.57 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $106.10 | $105.27 |
| 52 Week High | $176.19 | $137.49 |
Technical Indicators
Market Signals| Indicator | RY | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 38.34 | 46.53 |
| Support Level | $143.26 | $111.18 |
| Resistance Level | $175.21 | $113.76 |
| Average True Range (ATR) | 3.10 | 1.88 |
| MACD | -0.95 | -0.00 |
| Stochastic Oscillator | 18.34 | 48.50 |
Price Performance
Historical ComparisonAbout RY Royal Bank Of Canada
Royal Bank of Canada is one of the two largest banks in Canada, with around CAD 2.3 trillion in assets at the end of fiscal 2025. It is a diversified financial services company, offering personal and commercial banking, wealth management, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada and has dominant market shares. RBC also has wealth and capital market businesses in the US, UK, and other countries. RBC is a top 15 investment bank globally.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.